Trials / Recruiting
RecruitingNCT06353087
Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry)
The Real-world Treatment Patterns and Clinical Outcomes in Moderate-to-severe Atopic Dermatitis (AD) Patients Receiving Abrocitinib
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
This study is to describe the real-world treatment patterns and clinical outcomes in moderate-to-severe AD patients receiving abrocitinib over a 12-month observation period, and to describe patient demographic and baseline characteristics.
Conditions
Timeline
- Start date
- 2024-07-01
- Primary completion
- 2026-05-15
- Completion
- 2026-05-15
- First posted
- 2024-04-08
- Last updated
- 2025-09-03
Locations
8 sites across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT06353087. Inclusion in this directory is not an endorsement.